Your browser doesn't support javascript.
loading
Prodrug-Based Targeting Approach for Inflammatory Bowel Diseases Therapy: Mechanistic Study of Phospholipid-Linker-Cyclosporine PLA2-Mediated Activation.
Markovic, Milica; Abramov-Harpaz, Karina; Regev, Clil; Ben-Shabat, Shimon; Aponick, Aaron; Zimmermann, Ellen M; Miller, Yifat; Dahan, Arik.
Afiliación
  • Markovic M; Department of Clinical Pharmacology, School of Pharmacy, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva 8410501, Israel.
  • Abramov-Harpaz K; Department of Chemistry, Ben-Gurion University of the Negev, Beer-Sheva 8410501, Israel.
  • Regev C; Ilse Katz Institute for Nanoscale Science and Technology, Ben-Gurion University of the Negev, Beer-Sheva 8410501, Israel.
  • Ben-Shabat S; Department of Chemistry, Ben-Gurion University of the Negev, Beer-Sheva 8410501, Israel.
  • Aponick A; Ilse Katz Institute for Nanoscale Science and Technology, Ben-Gurion University of the Negev, Beer-Sheva 8410501, Israel.
  • Zimmermann EM; Department of Clinical Pharmacology, School of Pharmacy, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva 8410501, Israel.
  • Miller Y; Department of Chemistry, University of Florida, Gainesville, FL 32603, USA.
  • Dahan A; Department of Medicine, Division of Gastroenterology, University of Florida, Gainesville, FL 32610, USA.
Int J Mol Sci ; 23(5)2022 Feb 28.
Article en En | MEDLINE | ID: mdl-35269813

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Profármacos / Enfermedades Inflamatorias del Intestino Idioma: En Revista: Int J Mol Sci Año: 2022 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Profármacos / Enfermedades Inflamatorias del Intestino Idioma: En Revista: Int J Mol Sci Año: 2022 Tipo del documento: Article